Yext Offers Answers Product for Free to Help Brands Deliver Accurate and Timely Information about COVID-19

NEW YORK, March 12, 2020 /PRNewswire/ — Yext, Inc. (NYSE: YEXT), the Search Experience Cloud company, today announced that it is offering for free its new site search product, Yext Answers, to help brands in the wake of the global COVID-19 pandemic.

For a 90-day period, eligible businesses across industries will be able to transform their own website into a powerful search engine capable of answering consumers’ COVID-19 specific queries in real-time.

“Wrong answers can cost a company real business any day of the week, but in a time like this — the COVID-19 pandemic — wrong answers can actually cost lives,” said Howard Lerman, Founder and CEO of Yext. “Whether it’s a question to a healthcare provider about the efficacy of hand sanitizer, an airline about their cancellation policies, or a grocery store about the availability of bottled water, it’s imperative we help businesses across all industries deliver these coronavirus-related answers immediately and accurately.”

Businesses can register and learn more about this offer at www.nowronganswers.com and start the process of getting Yext Answers implemented on their own website. Additionally, participating companies can implement Yext’s free COVID-19 Knowledge Graph plug-in to add Frequently Asked Questions about coronavirus — sourced directly from the US Centers for Disease Control and Prevention (CDC) — to their own website’s search experience.

Click here to learn more about the free Yext Answers offer.

About Yext
The customer journey starts with a question, and every day consumers search for answers about brands. However, they are increasingly served false or misleading information from sources other than the brand. Yext (NYSE: YEXT), the Search Experience Cloud company, exists to help brands regain and maintain a direct relationship with their customers. With a mission to provide perfect answers everywhere, Yext puts businesses in control of their facts online by delivering brand verified answers straight from the source — wherever their customers are searching. Companies like Taco Bell, Marriott, Jaguar-Land Rover, and businesses around the world use Yext to take back control of the customer journey, starting on their own website.

Yext has been named a Best Place to Work by Fortune and Great Place to Work®, as well as a Best Workplace for Women. Yext is headquartered in New York City with offices in Amsterdam, Berlin, Chicago, Dallas, Geneva, London, Miami, Milan, Paris, San Francisco, Shanghai, Tokyo, and the Washington, D.C. area.

View original content to download multimedia:http://www.prnewswire.com/news-releases/yext-offers-answers-product-for-free-to-help-brands-deliver-accurate-and-timely-information-about-covid-19-301022465.html

SOURCE Yext, Inc.

Staff

Recent Posts

RESPIREE SECURES SINGAPORE HSA APPROVAL FOR ITS AI-ENABLED 1BIO™AI SOFTWARE TO SUPPORT ACUTE DETERIORATION DETECTION

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- AI/ML health-tech startup Respiree has received approval from the Health…

35 minutes ago

AI-for-Science Startup ChemLex Raises USD 45M, Launching Self-Driving Lab for Drug Discovery in Singapore

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- ChemLex, a next-generation AI-for-science company, today announced the establishment…

35 minutes ago

Is The DEA in Systemic Collapse: Corruption, Constitutional Violations, and a Seven-Year War Against Marijuana Medical Science

The DEA was created to combat cartel trafficking, protect public health, and ensure researchers have…

16 hours ago

Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease

CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology…

16 hours ago

Secura Bio Presents Extended Follow Up Analyses from Phase 2 PRIMO Trial in Patients with Relapsed/Refractory peripheral T-cell lymphoma at the 2025 American Society of Hematology Meeting

Longer-term analyses reinforce duvelisib’s activity across treatment-experienced PTCL populations, including patients with ≥3 prior lines…

16 hours ago